201 related articles for article (PubMed ID: 16087682)
1. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
Proks P; Girard C; Ashcroft FM
Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
[TBL] [Abstract][Full Text] [Related]
2. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
[TBL] [Abstract][Full Text] [Related]
5. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
Tammaro P; Proks P; Ashcroft FM
J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
[TBL] [Abstract][Full Text] [Related]
7. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
Proks P; de Wet H; Ashcroft FM
J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
[TBL] [Abstract][Full Text] [Related]
8. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
Tarasov AI; Girard CA; Larkin B; Tammaro P; Flanagan SE; Ellard S; Ashcroft FM
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():46-55. PubMed ID: 17919178
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
[TBL] [Abstract][Full Text] [Related]
11. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
[TBL] [Abstract][Full Text] [Related]
12. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
Winkler M; Lutz R; Russ U; Quast U; Bryan J
J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
[TBL] [Abstract][Full Text] [Related]
14. Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.
Lin CW; Lin YW; Yan FF; Casey J; Kochhar M; Pratt EB; Shyng SL
Diabetes; 2006 Jun; 55(6):1738-46. PubMed ID: 16731837
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Proks P; de Wet H; Ashcroft FM
Diabetes; 2013 Nov; 62(11):3909-19. PubMed ID: 23835339
[TBL] [Abstract][Full Text] [Related]
16. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
Gloyn AL; Reimann F; Girard C; Edghill EL; Proks P; Pearson ER; Temple IK; Mackay DJ; Shield JP; Freedenberg D; Noyes K; Ellard S; Ashcroft FM; Gribble FM; Hattersley AT
Hum Mol Genet; 2005 Apr; 14(7):925-34. PubMed ID: 15718250
[TBL] [Abstract][Full Text] [Related]
17. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
Proks P; Shimomura K; Craig TJ; Girard CA; Ashcroft FM
Hum Mol Genet; 2007 Aug; 16(16):2011-9. PubMed ID: 17584766
[TBL] [Abstract][Full Text] [Related]
19. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
Shimomura K; Girard CA; Proks P; Nazim J; Lippiat JD; Cerutti F; Lorini R; Ellard S; Hattersley AT; Barbetti F; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1705-12. PubMed ID: 16731833
[TBL] [Abstract][Full Text] [Related]
20. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]